 |
PDBsum entry 1cdy
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
T-cell surface glycoprotein
|
PDB id
|
|
|
|
1cdy
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Proc Natl Acad Sci U S A
93:15030-15035
(1996)
|
|
PubMed id:
|
|
|
|
|
| |
|
Kinetic and structural analysis of mutant CD4 receptors that are defective in HIV gp120 binding.
|
|
H.Wu,
D.G.Myszka,
S.W.Tendian,
C.G.Brouillette,
R.W.Sweet,
I.M.Chaiken,
W.A.Hendrickson.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The T-cell antigen coreceptor CD4 also serves as the receptor for the envelope
glycoprotein gp120 of HIV. Extensive mutational analysis of CD4 has implicated
residues from a portion of the extracellular amino-terminal domain (D1) in gp120
binding. However, none of these proteins has been fully characterized
biophysically, and thus the precise effects on molecular structure and binding
interactions are unknown. In the present study, we produced soluble versions of
three mutant CD4 molecules (F43V, G47S, and A55F) and characterized their
structural properties, thermostability, and ability to bind gp120.
Crystallographic and thermodynamic analysis showed minimal structural
alterations in the F43V and G47S mutant proteins, which have solvent-exposed
mutant side chains. In contrast, some degree of disorder appears to exist in the
folded state of A55F, as a result of mutating a buried side chain. Real time
kinetic measurements of the interaction of the mutant proteins with gp120 showed
affinity decreases of 5-fold for G47S, 50-fold for A55F, and 200-fold for F43V.
Although both rate constants for the binding reaction were affected by these
mutations, the loss in affinity was mainly due to a decrease in on rates, with
less drastic changes occurring in the off rates. These observations suggest the
involvement of conformational adaptation in the CD4-gp120 interaction. Together,
the structural and kinetic data confirm that F43V is a critical residue in gp120
recognition site, which may also include main chain interactions at residue
Gly-47.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
T.S.Dermody,
E.Kirchner,
K.M.Guglielmi,
and
T.Stehle
(2009).
Immunoglobulin superfamily virus receptors and the evolution of adaptive immunity.
|
| |
PLoS Pathog,
5,
e1000481.
|
 |
|
|
|
|
 |
A.Forsman,
E.Beirnaert,
M.M.Aasa-Chapman,
B.Hoorelbeke,
K.Hijazi,
W.Koh,
V.Tack,
A.Szynol,
C.Kelly,
A.McKnight,
T.Verrips,
H.de Haard,
and
R.A.Weiss
(2008).
Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120.
|
| |
J Virol,
82,
12069-12081.
|
 |
|
|
|
|
 |
I.J.Juncadella,
R.Garg,
T.C.Bates,
E.R.Olivera,
and
J.Anguita
(2008).
The Ixodes scapularis salivary protein, salp15, prevents the association of HIV-1 gp120 and CD4.
|
| |
Biochem Biophys Res Commun,
367,
41-46.
|
 |
|
|
|
|
 |
J.Billington,
T.P.Hickling,
G.H.Munro,
C.Halai,
R.Chung,
G.G.Dodson,
and
R.S.Daniels
(2007).
Stability of a receptor-binding active human immunodeficiency virus type 1 recombinant gp140 trimer conferred by intermonomer disulfide bonding of the V3 loop: differential effects of protein disulfide isomerase on CD4 and coreceptor binding.
|
| |
J Virol,
81,
4604-4614.
|
 |
|
|
|
|
 |
T.Chou,
and
M.R.D'Orsogna
(2007).
Multistage adsorption of diffusing macromolecules and viruses.
|
| |
J Chem Phys,
127,
105101.
|
 |
|
|
|
|
 |
A.T.Neffe,
M.Bilang,
and
B.Meyer
(2006).
Synthesis and optimization of peptidomimetics as HIV entry inhibitors against the receptor protein CD4 using STD NMR and ligand docking.
|
| |
Org Biomol Chem,
4,
3259-3267.
|
 |
|
|
|
|
 |
K.I.Lim,
and
J.Yin
(2006).
Dynamic tradeoffs in the raft-mediated entry of human immunodeficiency virus type 1 into cells.
|
| |
Biotechnol Bioeng,
93,
246-257.
|
 |
|
|
|
|
 |
J.B.Ames,
V.Vyas,
J.D.Lusin,
and
R.Mariuzza
(2005).
NMR structure of the natural killer cell receptor 2B4 (CD244): implications for ligand recognition.
|
| |
Biochemistry,
44,
6416-6423.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Martín-García,
S.Cocklin,
I.M.Chaiken,
and
F.González-Scarano
(2005).
Interaction with CD4 and antibodies to CD4-induced epitopes of the envelope gp120 from a microglial cell-adapted human immunodeficiency virus type 1 isolate.
|
| |
J Virol,
79,
6703-6713.
|
 |
|
|
|
|
 |
K.Arita,
H.Hashimoto,
T.Shimizu,
K.Nakashima,
M.Yamada,
and
M.Sato
(2004).
Structural basis for Ca(2+)-induced activation of human PAD4.
|
| |
Nat Struct Mol Biol,
11,
777-783.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.L.Rich,
and
D.G.Myszka
(2003).
Spying on HIV with SPR.
|
| |
Trends Microbiol,
11,
124-133.
|
 |
|
|
|
|
 |
X.Yu,
Q.Y.Wang,
Y.Guo,
K.Dolmer,
J.A.Young,
P.G.Gettins,
and
L.Rong
(2003).
Kinetic analysis of binding interaction between the subgroup A Rous sarcoma virus glycoprotein SU and its cognate receptor Tva: calcium is not required for ligand binding.
|
| |
J Virol,
77,
7517-7526.
|
 |
|
|
|
|
 |
N.E.Robinson,
and
A.B.Robinson
(2001).
Prediction of protein deamidation rates from primary and three-dimensional structure.
|
| |
Proc Natl Acad Sci U S A,
98,
4367-4372.
|
 |
|
|
|
|
 |
D.G.Myszka,
R.W.Sweet,
P.Hensley,
M.Brigham-Burke,
P.D.Kwong,
W.A.Hendrickson,
R.Wyatt,
J.Sodroski,
and
M.L.Doyle
(2000).
Energetics of the HIV gp120-CD4 binding reaction.
|
| |
Proc Natl Acad Sci U S A,
97,
9026-9031.
|
 |
|
|
|
|
 |
P.D.Kwong,
R.Wyatt,
S.Majeed,
J.Robinson,
R.W.Sweet,
J.Sodroski,
and
W.A.Hendrickson
(2000).
Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates.
|
| |
Structure,
8,
1329-1339.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
U.Esser,
R.F.Speck,
K.C.Deen,
R.E.Atchison,
R.Sweet,
and
M.A.Goldsmith
(2000).
Molecular function of the CD4 D1 domain in coreceptor-mediated entry by HIV type 1.
|
| |
AIDS Res Hum Retroviruses,
16,
1845-1854.
|
 |
|
|
|
|
 |
G.Zeder-Lutz,
A.Benito,
and
M.H.Van Regenmortel
(1999).
Active concentration measurements of recombinant biomolecules using biosensor technology.
|
| |
J Mol Recognit,
12,
300-309.
|
 |
|
|
|
|
 |
M.Ferrer,
and
S.C.Harrison
(1999).
Peptide ligands to human immunodeficiency virus type 1 gp120 identified from phage display libraries.
|
| |
J Virol,
73,
5795-5802.
|
 |
|
|
|
|
 |
M.Fivash,
E.M.Towler,
and
R.J.Fisher
(1998).
BIAcore for macromolecular interaction.
|
| |
Curr Opin Biotechnol,
9,
97.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |